US Plans For End Of Covid-19 Shot, Treatment Coverage - WSJ
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Pfizer (PFE) Ordered by FDA to Test Impact of Repeat Course of Paxlovid - BBG
August 19, 2022 3:48 PM EDTUS regulators ordered Pfizer (NYSE: PFE) to test the impact of an extra course of Paxlovid in people who experience a rebound in Covid-19 following treatment, Bloomberg reported Friday.
Bloomberg stated the drug will go through a further study after reports of the "mysterious phenomenon" continue to rise.... More
Moderna (MRNA), Pfizer (PFE) on Watch Following Report U.S. Plans for End of Coverage for Covid Shots, Treatments
August 18, 2022 12:03 PM EDTModerna (NASDAQ: MRNA), Pfizer (NYSE: PFE) on Watch Following Report U.S. Plans for End of Coverage for Covid Shots, Treatments
... More